Search is Powered by Google
Pharma Industry / Biotech Industry News

ISPE And FDC-Windhover Team Up To Offer PharmAsia News

Main Category: Pharma Industry / Biotech Industry
Article Date: 18 Nov 2008 - 4:00 PST

email icon email to a friend   printer icon printer friendly   write icon view / write opinions   rate icon rate article
Current Article Ratings:

Patient / Public:not yet rated

Health Professional:not yet rated

Article Opinions: 0 posts

ISPE, a global not-for-profit association of 25,000 pharmaceutical science and manufacturing professionals, and FDC-Windhover announced today that the two organizations have teamed up to provide discounted subscriptions of PharmAsia News to ISPE Members, as well as complimentary access to monthly articles.

"As the Asian pharmaceutical industry continues to grow, PharmaAsia News will be a valuable resource for our Members as they work, serve, and network with their pharmaceutical industry counterparts," said Robert P. Best, ISPE's President and CEO.

Leveraging the high editorial quality of FDC Reports' The Pink Sheet, PharmAsia News provides information regarding the regulatory, legal, and financial developments affecting pharmaceutical, biologics, and medical device manufacturers doing business in China, India, Japan, and the Pacific Rim.

The first complimentary article being offered is entitled GSK Managing Director Hasit Joshipura On What Lies Ahead for India's Largest Multinational Drug Company: An Interview with PharmAsia News. Once downloading the article, ISPE Members will receive a certificate for a one-year discounted subscription to PharmAsia News.

Visit http://offers.fdcreports.com/ISPER/ to access a complimentary article from PharmAsia News and for more information about a discounted subscription for ISPE Members.

About ISPE

ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 25,000 pharmaceutical science and manufacturing professionals in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop technical knowledge, exchange practical experience, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE has worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; its Asia Pacific office in Singapore; and its newly established office in Shanghai, China.. Visit www.ISPE.org for additional Society news and information.

About PharmAsia News

PharmAsia News covers regulatory, legal, and financial developments affecting pharmaceutical, biologics, and medical device manufacturers doing business in China, India, Japan, and the Pacific Rim. News bureaus across Asia provide around-the-clock coverage on the web and twice-weekly e-mail newsletters to help readers stay on top of these rapidly developing markets. PharmAsiaNews leverages the editorial excellence of "The Pink Sheet," the leading information source for the U.S. pharmaceutical industry since 1939. http://www.pharmasianews.com

Source
Elizabeth Pierre-Saint
Communications Coordinator, ISPE
3109 W. Dr. Martin Luther King Jr. Blvd.
Tampa, FL 33607
http://www.ISPE.org
ISPE - Engineering Pharmaceutical Innovation




Personalized Homepage Weekly Newsletters Daily News Alerts
Opioid Induced Constipation ADHD Anxiety Asthma Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles All 'How To...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Swine Flu Image

Swine Flu Updates

- Latest Swine Flu News
- What is Swine Flu?
- Map Of H1N1 Outbreaks
- Swine Flu - Top 20 FAQ
- Daily Email News Alerts
Stick with Medical News Today for the latest news updates on swine flu.


These are the most read articles from this news category for the last 6 months:
Top Article Star
Sanofi Aventis Invests 100 Million Euros In New Facility In Mexico To Produce Seasonaland Pandemic Influenza Vaccine
19 Mar 2009
Sanofi-aventis (EURONEXT: SAN and NYSE: SNY), announced the signing of an agreement with the Mexican authorities to build a 100 million euro facility to manufacture influenza vaccine in Mexico...


Diagnosing Vision Problems in Children
Diagnosing Vision Problems in Children

Children with vision problems are often misidentified as having learning disabilities, especially since the kids themselves may not be aware there's a problem with their sight. But parents should look for warning signs of vision trouble.

more videos are available in our health videos section.